The activated endocannabinoid system in atherosclerosis: driving force or protective mechanism? [electronic resource]
Producer: 20160107Description: 334-41 p. digitalISSN:- 1873-5592
- Atherosclerosis -- drug therapy
- Blood Pressure
- Cannabinoid Receptor Agonists -- therapeutic use
- Cannabinoid Receptor Antagonists -- therapeutic use
- Cardiovascular System -- drug effects
- Cholesterol -- metabolism
- Endocannabinoids -- metabolism
- Humans
- Molecular Targeted Therapy
- Myocardial Contraction
- Protective Factors
- Receptor, Cannabinoid, CB1 -- antagonists & inhibitors
- Receptor, Cannabinoid, CB2 -- agonists
- Risk Factors
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.